PATENT CLAIM ANALYSIS

Application Number: 15867056
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "031000"]

Abstract:
Compositions and methods for inhibiting Leishmaniasis using AIs are provided. Aspects provide compositions and methods for administering AIs alone or in combination with other compounds to infected hosts.

Claim (Index 14):
The composition of  claim 13 , wherein the AI is AR-12.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 86.0
- Lexical Diversity: 1.2
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14924605', '15411249', '14632647', '11991080', '15425481']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7198527376886636
- 35 USC 102 Novelty (BERT): 0.5179827335321048
- Combined Prediction Score: 0.6996657372730078
- Mean Citation Score: 147.1053302
- Max Citation Score: 273.31207
- Similarity Product: 173.0722612991834

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test